Version Française
Logo retour accueil

Last news

  • New paper published in "Frontiers in Pediatrics"

    A new paper based on an IntegraGen-sponsored survey of parents of children with autism spectrum disroder has been published in "Frontiers in Pediatris".  

    Read more

  • IntegraGen announces 2013 financial results

    Integragen today announced its financial results for the year ended 31 December 2013. 

    Read more


IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests for autism and oncology based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on it's technological expertise and scientific know how.

Autism Oncology Services
Disclaimers - Mentions légales - Crédits